Found 0 matching trials
Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer - a Combination Immunotherapy Phase Ib Study.
PHASE1The primary hypothesis is that cancer vaccine can convert non-immunogenic g...
Location
National University Hospital
Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma
PHASE2This is a prospective, monocenter, single arm, phase II trial in 33 patient...
Location
Netherlands Cancer Institute-Antoni van Leeuwenhoek Ziekenhuis
Neoadjuvant Anti-PD1 in HCC
PHASE2This is a phase 2, single-arm trial designed to assess the clinical benefit...
Location
Queen Mary Hospital
Cabozantinib and Nivolumab for Carcinoid Tumors
PHASE2This research study, is studying the combination of cabozantinib and nivolu...
Location
Boston Medical Center
Drug Screening Using Novel IMD in Renal Cell Carcinoma
PHASE1This research is being done to study the safety and feasibility of implanti...
Location
Dana-Farber Cancer Institute
Neoadjuvant Immunotherapy in Brain Metastases
PHASE2The purpose of this phase 2 study is to assess the feasibility and efficacy...
Location
Duke University Medical Center
A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
PHASE1This is a multicenter, randomized, double-blind, parallel-controlled phase ...
Location
Fujian Medical University Union Hospital
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
PHASE1This phase I trial tests the safety, side effects, and best dose of nivolum...
Location
University of Alabama at Birmingham Cancer Center
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App
N/AThis study is being done to better understand patient experiences with usin...
Location
Mayo Clinic in Rochester
Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer
N/AManagements for refractory proficient mismatch repair (pMMR) or microsatell...
Location
Hunan Cancer hospital